Back to Condition
Achromatopsia
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Achromatopsia

Achromatopsia is a vision disorder characterized by problems with color perception, ranging from complete absence of color vision to partial, often accompanied by increased light sensitivity, involuntary eye movements, and reduced visual sharpness.

Overview

Achromatopsia is a disorder that causes problems with color vision. The retina, which is the light-sensitive tissue at the back of the eye, contains two types of light receptor cells called rods and cones. Rods provide vision in low light (night vision), while cones provide vision in bright light (daytime vision). Cones are also responsible for color vision.

There are two types of achromatopsia: complete and incomplete. People with complete achromatopsia cannot perceive any color; they see only black, white, and shades of gray. People with incomplete achromatopsia can see some color.

Achromatopsia affects approximately 1 in 30,000 people worldwide. Complete achromatopsia is more common than incomplete achromatopsia.

Complete achromatopsia occurs more frequently among Pingelapese islanders, who live in parts of Micronesia in the western Pacific Ocean. Between 4 and 10 percent of people in this population have a total absence of color vision.

Symptoms

People with achromatopsia may have additional problems with their vision, including an increased sensitivity to light and glare (photophobia), involuntary back-and-forth eye movements (nystagmus), and significantly reduced sharpness of vision (low visual acuity). Affected individuals may also have a small visual blind spot (scotoma), farsightedness, or nearsightedness.

Achromatopsia is different from the more common forms of color vision deficiency (also called color blindness), in which people can perceive color but have difficulty distinguishing between certain colors, such as red and green. One form of color blindness, called blue cone monochromacy (BCM), is sometimes considered a form of incomplete achromatopsia.

Causes

Variants (also called mutations) in several different genes can cause achromatopsia. Most of the genes that are associated with achromatopsia are known to play important roles in the normal functioning of cones. Variants in the CNGA3 and CNGB3 genes are the most common causes of achromatopsia.

The CNGA3 and CNGB3 genes provide instructions for making different parts (subunits) of the cyclic nucleotide-gated (CNG) channel. These channels are found exclusively in cones and play an important role in a process called phototransduction. During phototransduction, rods and cones translate light into electrical signals. To help with this process, CNG channels transport positively charged atoms (ions) across the cell membrane and into cells. This movement of ions helps generate an electrical signal that is sent to the brain for interpretation.

Some of the variants in the CNGA3 and CNGB3 genes that are associated with achromatopsia cause cells to produce fewer CNG channel subunits, while other variants cause cells to produce subunits that do not function properly. These changes impair the function of the CNG channels, which disrupts the flow of ions across cell membranes and impairs the cell's ability to generate electrical signals.

Some people with achromatopsia do not have one of the gene variants known to cause the condition. In these individuals, the cause of the disorder is unknown.

Associated Genes

  • CNGA3
  • CNGB3
  • GNAT2
  • PDE6C
  • PDE6H

Additional Information from NCBI Gene:

  • ATF6

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell must have a variant to cause the disorder. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

Other Names for This Condition

  • ACHM
  • Achromatism
  • Rod monochromatism

Frequently Asked Questions

Wear high‑quality sunglasses or photochromic lenses that block at least 99 % of UV and blue light, use wide‑brimmed hats outdoors, install dimmable or tinted lighting at home and work, and consider using screen filters or “night mode” on electronic devices. Adding a brim to indoor lighting fixtures and avoiding glare from reflective surfaces (e.g., glossy tables) can also help.;How can I improve the sharpness of my vision for reading or recognizing faces—are there special glasses or low‑vision devices for achromatopsia?::Standard corrective lenses may address refractive errors (myopia or hyperopia) but do not restore color or cone function. Low‑vision aids such as high‑contrast, large‑print reading materials, magnifiers, telescopic glasses, and electronic video magnifiers can enhance detail. Some patients benefit from custom tinted lenses that reduce glare while preserving contrast; consult a low‑vision specialist for a personalized device plan.;Is genetic testing useful for confirming whether I have complete or incomplete achromatopsia, and how does the result affect family planning?::Yes. Molecular testing of the CNGA3, CNGB3, GNAT2, PDE6C, and PDE6H genes can identify pathogenic variants and often predicts the phenotype (complete vs. incomplete). A confirmed autosomal‑recessive result means each parent is a carrier; siblings have a 25 % chance of being affected. Couples can consider carrier screening, pre‑implantation genetic diagnosis, or prenatal testing if they wish to avoid passing the condition to future children.;My child was diagnosed with achromatopsia at age 5; is there any therapy that can improve vision over time?::Currently there is no cure, and cone cells do not regenerate spontaneously. However, emerging gene‑replacement trials (e.g., sub‑retinal AAV‑mediated delivery) are showing promise in early-phase studies. In the meantime, early enrollment in low‑vision rehabilitation, orientation‑mobility training, and consistent use of photoprotective strategies can maximize functional vision and quality of life.;
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab